LiMM

LiMM
LiMM
LiMM is a startup based in Paris, France. It is a bio-pharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. By decoding the language of the neuroimmune cross-talk, The company is developing first-in-class therapeutic products – NRILs. It was founded in 2017.
Paris
Bio-pharmaceutical, Health, Treatment
Between €2.5 million-5 million
2017
www.limmtx.com/

Articles about LiMM:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as LiMM? We’re happy to assist you with our Startup Sourcing service.